Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Pharmacokinetic drug interactions of the non-vitamin K antagonist oral anticoagulants (NOACs).

Gelosa P, Castiglioni L, Tenconi M, Baldessin L, Racagni G, Corsini A, Bellosta S.

Pharmacol Res. 2018 Sep;135:60-79. doi: 10.1016/j.phrs.2018.07.016. Epub 2018 Jul 21. Review.

PMID:
30040996
2.

Proprotein Convertase Subtilisin-Kexin type-9 (PCSK9) and triglyceride-rich lipoprotein metabolism: Facts and gaps.

Baragetti A, Grejtakova D, Casula M, Olmastroni E, Jotti GS, Norata GD, Catapano AL, Bellosta S.

Pharmacol Res. 2018 Apr;130:1-11. doi: 10.1016/j.phrs.2018.01.025. Epub 2018 Feb 8. Review.

PMID:
29428206
3.

The dataset describes: Phenotypic changes induced by cholesterol loading in smooth muscle cells isolated from the aortae of C57BL/6 mice.

Castiglioni S, Monti M, Buscherini GA, Arnaboldi L, Canavesi M, Corsini A, Bellosta S.

Data Brief. 2017 Nov 20;16:334-340. doi: 10.1016/j.dib.2017.11.050. eCollection 2018 Feb.

4.

Statin drug interactions and related adverse reactions: an update.

Bellosta S, Corsini A.

Expert Opin Drug Saf. 2018 Jan;17(1):25-37. doi: 10.1080/14740338.2018.1394455. Epub 2017 Oct 30. Review.

PMID:
29058944
5.

ABCA1 and HDL3 are required to modulate smooth muscle cells phenotypic switch after cholesterol loading.

Castiglioni S, Monti M, Arnaboldi L, Canavesi M, Ainis Buscherini G, Calabresi L, Corsini A, Bellosta S.

Atherosclerosis. 2017 Nov;266:8-15. doi: 10.1016/j.atherosclerosis.2017.09.012. Epub 2017 Sep 18.

PMID:
28946038
6.

Pharmacokinetics interactions of monoclonal antibodies.

Ferri N, Bellosta S, Baldessin L, Boccia D, Racagni G, Corsini A.

Pharmacol Res. 2016 Sep;111:592-599. doi: 10.1016/j.phrs.2016.07.015. Epub 2016 Jul 18. Review.

PMID:
27438459
7.

Cigarette smoke condensate affects monocyte interaction with endothelium.

Giunzioni I, Bonomo A, Bishop E, Castiglioni S, Corsini A, Bellosta S.

Atherosclerosis. 2014 Jun;234(2):383-90. doi: 10.1016/j.atherosclerosis.2014.03.029. Epub 2014 Apr 1.

PMID:
24747113
8.

Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties.

Ferri N, Corsini A, Bellosta S.

Drugs. 2013 Oct;73(15):1681-709. doi: 10.1007/s40265-013-0126-z. Review.

PMID:
24114622
9.

Nitric oxide-donating atorvastatin attenuates neutrophil recruitment during vascular inflammation independent of changes in plasma cholesterol.

Baetta R, Granata A, Miglietta D, Oliva F, Arnaboldi L, Bonomo A, Ferri N, Ongini E, Bellosta S, Corsini A.

Cardiovasc Drugs Ther. 2013 Jun;27(3):211-9. doi: 10.1007/s10557-013-6445-1.

PMID:
23400638
10.

Cholesterol: its regulation and role in central nervous system disorders.

Orth M, Bellosta S.

Cholesterol. 2012;2012:292598. doi: 10.1155/2012/292598. Epub 2012 Oct 17.

11.

Statin drug interactions and related adverse reactions.

Bellosta S, Corsini A.

Expert Opin Drug Saf. 2012 Nov;11(6):933-46. doi: 10.1517/14740338.2012.712959. Epub 2012 Aug 7. Review.

PMID:
22866966
12.

Free cholesterol alters macrophage morphology and mobility by an ABCA1 dependent mechanism.

Adorni MP, Favari E, Ronda N, Granata A, Bellosta S, Arnaboldi L, Corsini A, Gatti R, Bernini F.

Atherosclerosis. 2011 Mar;215(1):70-6. doi: 10.1016/j.atherosclerosis.2010.12.004. Epub 2010 Dec 15.

PMID:
21215399
13.

Olive oil phenols modulate the expression of metalloproteinase 9 in THP-1 cells by acting on nuclear factor-kappaB signaling.

Dell'Agli M, Fagnani R, Galli GV, Maschi O, Gilardi F, Bellosta S, Crestani M, Bosisio E, De Fabiani E, Caruso D.

J Agric Food Chem. 2010 Feb 24;58(4):2246-52. doi: 10.1021/jf9042503.

PMID:
20102205
14.

Everolimus inhibits monocyte/macrophage migration in vitro and their accumulation in carotid lesions of cholesterol-fed rabbits.

Baetta R, Granata A, Canavesi M, Ferri N, Arnaboldi L, Bellosta S, Pfister P, Corsini A.

J Pharmacol Exp Ther. 2009 Feb;328(2):419-25. doi: 10.1124/jpet.108.144147. Epub 2008 Nov 20.

PMID:
19023042
15.

Mediterranean diet and cardioprotection: wild artichoke inhibits metalloproteinase 9.

Bellosta S, Bogani P, Canavesi M, Galli C, Visioli F.

Mol Nutr Food Res. 2008 Oct;52(10):1147-52. doi: 10.1002/mnfr.200700502.

PMID:
18646006
16.

Drug-drug interaction with statins.

Corsini A, Bellosta S.

Expert Rev Clin Pharmacol. 2008 Jan;1(1):105-13. doi: 10.1586/17512433.1.1.105.

PMID:
24410514
17.

Thiol supplementation inhibits metalloproteinase activity independent of glutathione status.

Bogani P, Canavesi M, Hagen TM, Visioli F, Bellosta S.

Biochem Biophys Res Commun. 2007 Nov 23;363(3):651-5. Epub 2007 Sep 18.

PMID:
17900531
18.

Raloxifene inhibits matrix metalloproteinases expression and activity in macrophages and smooth muscle cells.

Bellosta S, Baetta R, Canavesi M, Comparato C, Granata A, Monetti M, Cairoli F, Eberini I, Puglisi L, Corsini A.

Pharmacol Res. 2007 Aug;56(2):160-7. Epub 2007 May 16.

PMID:
17582780
19.

Perivascular carotid collar placement induces neointima formation and outward arterial remodeling in mice independent of apolipoprotein E deficiency or Western-type diet feeding.

Baetta R, Silva F, Comparato C, Uzzo M, Eberini I, Bellosta S, Donetti E, Corsini A.

Atherosclerosis. 2007 Nov;195(1):e112-24. Epub 2007 May 4.

PMID:
17482195
20.

Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats.

Gianella A, Nobili E, Abbate M, Zoja C, Gelosa P, Mussoni L, Bellosta S, Canavesi M, Rottoli D, Guerrini U, Brioschi M, Banfi C, Tremoli E, Remuzzi G, Sironi L.

Am J Pathol. 2007 Apr;170(4):1165-77.

21.

Rosuvastatin displays anti-atherothrombotic and anti-inflammatory properties in apoE-deficient mice.

Monetti M, Canavesi M, Camera M, Parente R, Paoletti R, Tremoli E, Corsini A, Bellosta S.

Pharmacol Res. 2007 May;55(5):441-9. Epub 2007 Feb 12.

PMID:
17350858
22.

Inhibition of MMP-2 activation and release as a novel mechanism for HDL-induced cardioprotection.

Bellosta S, Gomaraschi M, Canavesi M, Rossoni G, Monetti M, Franceschini G, Calabresi L.

FEBS Lett. 2006 Oct 30;580(25):5974-8. Epub 2006 Oct 12.

23.

Hypolipidemic therapy for the metabolic syndrome.

Cignarella A, Bellosta S, Corsini A, Bolego C.

Pharmacol Res. 2006 Jun;53(6):492-500. Epub 2006 Mar 27. Review.

PMID:
16621589
24.

Modulation of macrophage function and metabolism.

Bellosta S, Bernini F.

Handb Exp Pharmacol. 2005;(170):665-95. Review.

PMID:
16596819
25.

A structure-activity study for the inhibition of metalloproteinase-9 activity and gene expression by analogues of gallocatechin-3-gallate.

Dell'agli M, Bellosta S, Rizzi L, Galli GV, Canavesi M, Rota F, Parente R, Bosisio E, Romeo S.

Cell Mol Life Sci. 2005 Dec;62(23):2896-903.

PMID:
16314917
26.

Pharmacokinetic interactions between statins and fibrates.

Corsini A, Bellosta S, Davidson MH.

Am J Cardiol. 2005 Nov 7;96(9A):44K-49K; discussion 34K-35K. Epub 2005 Oct 21.

PMID:
16291014
27.

PPAR alpha inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a.

Gizard F, Amant C, Barbier O, Bellosta S, Robillard R, Percevault F, Sevestre H, Krimpenfort P, Corsini A, Rochette J, Glineur C, Fruchart JC, Torpier G, Staels B.

J Clin Invest. 2005 Nov;115(11):3228-38.

28.

Statins effect on smooth muscle cell proliferation.

Bellosta S, Arnaboldi L, Gerosa L, Canavesi M, Parente R, Baetta R, Paoletti R, Corsini A.

Semin Vasc Med. 2004 Nov;4(4):347-56. Review.

PMID:
15861311
29.

Dietary polyphenols and regulation of gelatinase expression and activity.

Dell'Agli M, Canavesi M, Galli G, Bellosta S.

Thromb Haemost. 2005 Apr;93(4):751-60. Review.

PMID:
15841324
30.

In vitro inhibitory effect of lercanidipine on cholesterol accumulation and matrix metalloproteinases secretion by macrophages.

Canavesi M, Baldini N, Leonardi A, Sironi G, Bellosta S, Bernini F.

J Cardiovasc Pharmacol. 2004 Oct;44(4):416-22.

31.

Safety of statins: focus on clinical pharmacokinetics and drug interactions.

Bellosta S, Paoletti R, Corsini A.

Circulation. 2004 Jun 15;109(23 Suppl 1):III50-7. Review.

32.

Synthesis, structure and conformation of partially-modified retro- and retro-inverso psi[NHCH(CF3)]Gly peptides.

Volonterio A, Bellosta S, Bravin F, Bellucci MC, Bruché L, Colombo G, Malpezzi L, Mazzini S, Meille SV, Meli M, Ramírez De Arellano C, Zanda M.

Chemistry. 2003 Sep 22;9(18):4510-22.

PMID:
14502637
33.

Inhibition of metalloproteinase-9 activity and gene expression by polyphenolic compounds isolated from the bark of Tristaniopsis calobuxus (Myrtaceae).

Bellosta S, Dell'Agli M, Canavesi M, Mitro N, Monetti M, Crestani M, Verotta L, Fuzzati N, Bernini F, Bosisio E.

Cell Mol Life Sci. 2003 Jul;60(7):1440-8.

PMID:
12943230
34.

Endogenous proteolytic activity in a rat model of spontaneous cerebral stroke.

Sironi L, Maria Calvio A, Bellosta S, Lodetti B, Guerrini U, Monetti M, Tremoli E, Mussoni L.

Brain Res. 2003 Jun 6;974(1-2):184-92.

PMID:
12742636
35.

Rupture of the atherosclerotic plaque: does a good animal model exist?

Cullen P, Baetta R, Bellosta S, Bernini F, Chinetti G, Cignarella A, von Eckardstein A, Exley A, Goddard M, Hofker M, Hurt-Camejo E, Kanters E, Kovanen P, Lorkowski S, McPheat W, Pentikäinen M, Rauterberg J, Ritchie A, Staels B, Weitkamp B, de Winther M; MAFAPS Consortium.

Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):535-42. Epub 2003 Feb 6. Review.

36.

Safety considerations for statins.

Bolego C, Baetta R, Bellosta S, Corsini A, Paoletti R.

Curr Opin Lipidol. 2002 Dec;13(6):637-44. Review.

PMID:
12441888
37.

[Rhabdomyolysis].

Corsini A, Bellosta S.

Ann Ital Med Int. 2002 Jul-Sep;17(3):146-8. Review. Italian. No abstract available.

PMID:
12402661
38.

Macrophage function and stability of the atherosclerotic plaque: progress report of a European project.

Bellosta S, Bernini F, Chinetti G, Cignarella A, Cullen P, von Eckardstein A, Exley A, Freeth J, Goddard M, Hofker M, Kanters E, Kovanen P, Lorkowski S, Pentikäinen M, Printen J, Rauterberg J, Ritchie A, Staels B, Weitkamp B, de Winther M; Macrophage Function and Stability of Atherosclerotic Plaque Consortium.

Nutr Metab Cardiovasc Dis. 2002 Feb;12(1):3-11. Review. No abstract available.

PMID:
12125228
39.

Pharmacological interactions of statins.

Paoletti R, Corsini A, Bellosta S.

Atheroscler Suppl. 2002 May;3(1):35-40. Review.

PMID:
12044584
40.

Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?

Comparato C, Altana C, Bellosta S, Baetta R, Paoletti R, Corsini A.

Nutr Metab Cardiovasc Dis. 2001 Oct;11(5):328-43. Review.

PMID:
11887430
41.

Lacidipine [correction of Lalsoacidipine] modulates the secretion of matrix metalloproteinase-9 by human macrophages.

Bellosta S, Canavesi M, Favari E, Cominacini L, Gaviraghi G, Fumagalli R, Paoletti R, Bernini F.

J Pharmacol Exp Ther. 2001 Mar;296(3):736-43. Erratum in: J Pharmacol Exp Ther 2001 May;297(2):827.

42.

Statin therapy and prevention of stroke.

Bellosta S, Paoletti R.

Curr Atheroscler Rep. 2000 May;2(3):181-2. No abstract available.

PMID:
11122742
43.

Lipophilic calcium antagonists in antiatherosclerotic therapy.

Bellosta S, Bernini F.

Curr Atheroscler Rep. 2000 Jan;2(1):76-81. Review.

PMID:
11122728
44.

Pleiotropic effects of statins in atherosclerosis and diabetes.

Bellosta S, Ferri N, Arnaboldi L, Bernini F, Paoletti R, Corsini A.

Diabetes Care. 2000 Apr;23 Suppl 2:B72-8.

PMID:
10860194
45.

Non-lipid-related effects of statins.

Bellosta S, Ferri N, Bernini F, Paoletti R, Corsini A.

Ann Med. 2000 Apr;32(3):164-76. Review.

PMID:
10821323
46.

New insights into the pharmacodynamic and pharmacokinetic properties of statins.

Corsini A, Bellosta S, Baetta R, Fumagalli R, Paoletti R, Bernini F.

Pharmacol Ther. 1999 Dec;84(3):413-28. Review. Erratum in: Pharmacol Ther 2000 May;86(2):199.

PMID:
10665838
47.

Natural anti-endothelial cell antibodies (AECA).

Ronda N, Leonardi S, Orlandini G, Gatti R, Bellosta S, Bernini F, Borghetti A.

J Autoimmun. 1999 Aug;13(1):121-7.

PMID:
10441176
48.

Best practice--ongoing polemics.

Paoletti R, Bellosta S.

Atherosclerosis. 1999 May;143 Suppl 1:S3-6. Review.

PMID:
10382831
49.

Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration.

Buttini M, Orth M, Bellosta S, Akeefe H, Pitas RE, Wyss-Coray T, Mucke L, Mahley RW.

J Neurosci. 1999 Jun 15;19(12):4867-80.

50.

Characterization of a new form of inherited hypercholesterolemia: familial recessive hypercholesterolemia.

Zuliani G, Arca M, Signore A, Bader G, Fazio S, Chianelli M, Bellosta S, Campagna F, Montali A, Maioli M, Pacifico A, Ricci G, Fellin R.

Arterioscler Thromb Vasc Biol. 1999 Mar;19(3):802-9.

Supplemental Content

Loading ...
Support Center